Izopet J - Search Results

1

Characterization of the Specificity, Functionality, and Durability of Host T-Cell Responses Against the Full-Length Hepatitis E Virus.

Brown A, Halliday JS, Swadling L, Madden RG, Bendall R, Hunter JG, Maggs J, Simmonds P, Smith DB, Vine L, McLaughlin C, Collier J, Bonsall D, Jeffery K, Dunachie S, Klenerman P, Izopet J, Kamar N, Dalton HR, Barnes E. Brown A, et al. Among authors: izopet j. Hepatology. 2016 Dec;64(6):1934-1950. doi: 10.1002/hep.28819. Epub 2016 Oct 28. Hepatology. 2016. PMID: 27631819 Free PMC article.

2

Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc).

Payen JL, Izopet J, Galindo-Migeot V, Lauwers-Cances V, Zarski JP, Seigneurin JM, Dussaix E, Voigt JJ, Selves J, Barange K, Puel J, Pascal JP. Payen JL, et al. Among authors: izopet j. Hepatology. 1998 Dec;28(6):1680-6. doi: 10.1002/hep.510280631. Hepatology. 1998. PMID: 9828235 Clinical Trial.

3

Evolution of hepatitis C virus quasispecies in renal transplant patients with de novo glomerulonephritis.

Kamar N, Rostaing L, Boulestin A, Sandres K, Dubois M, Ribes D, Modesto A, Durand D, Izopet J. Kamar N, et al. Among authors: izopet j. J Med Virol. 2003 Apr;69(4):482-8. doi: 10.1002/jmv.10335. J Med Virol. 2003. PMID: 12601755

4

[Is there a place for ribavirin in the treatment for renal transplant patients infected by hepatitis C virus?].

Kamar N, Sandres-Saune K, Selves J, Durand D, Izopet J, Rostaing L. Kamar N, et al. Among authors: izopet j. Nephrologie. 2003;24(2):89-94. Nephrologie. 2003. PMID: 12723514 French.

5

[Hepatitis C infection among patients receiving hemodialysis].

Kamar N, Izopet J, Rostaing L. Kamar N, et al. Among authors: izopet j. Nephrologie. 2003;24(3):133-41. Nephrologie. 2003. PMID: 12814060 Review. French.

6

Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology.

Kamar N, Sandres-Saune K, Selves J, Ribes D, Cointault O, Durand D, Izopet J, Rostaing L. Kamar N, et al. Among authors: izopet j. Am J Kidney Dis. 2003 Jul;42(1):184-92. doi: 10.1016/s0272-6386(03)00422-0. Am J Kidney Dis. 2003. PMID: 12830471 Clinical Trial.

7

Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation.

Kamar N, Toupance O, Buchler M, Sandres-Saune K, Izopet J, Durand D, Rostaing L. Kamar N, et al. Among authors: izopet j. J Am Soc Nephrol. 2003 Aug;14(8):2092-8. doi: 10.1097/01.asn.0000079613.81511.3c. J Am Soc Nephrol. 2003. PMID: 12874463

8

Ribavirin pharmacokinetics in renal and liver transplant patients: evidence that it depends on renal function.

Kamar N, Chatelut E, Manolis E, Lafont T, Izopet J, Rostaing L. Kamar N, et al. Among authors: izopet j. Am J Kidney Dis. 2004 Jan;43(1):140-6. doi: 10.1053/j.ajkd.2003.09.019. Am J Kidney Dis. 2004. PMID: 14712437

9

[Hepatitis C virus infection in renal-transplant patients].

Kamar N, Izopet J, Ribes D, Rostaing L. Kamar N, et al. Among authors: izopet j. Nephrologie. 2004;25(1):9-15. Nephrologie. 2004. PMID: 15022868 Review. French.

10

Amantadine therapy in renal transplant patients with hepatitis C virus infection.

Kamar N, Rostaing L, Sandres-Saune K, Ribes D, Durand D, Izopet J. Kamar N, et al. Among authors: izopet j. J Clin Virol. 2004 May;30(1):110-4. doi: 10.1016/j.jcv.2003.10.001. J Clin Virol. 2004. PMID: 15072764 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

687 results

Search Page

Filters